Skip to main content

 ANC: Neuroscience of Disease

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Editors-in-Chief

Jeroen Hoozemans, Amsterdam University Medical Centers, The Netherlands
Jason Huse, University of Texas MD Anderson Cancer Center, USA

Aims and scope

Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques

Call for Papers - Traumatic Brain Injury

Elder et al., 2013 © Elder et al., 2013We are excited to announce an open call for papers focusing on clinical, basic science, and translational studies that address current problems and knowledge gaps in TBI, which affects over 65 million people worldwide each year.

This series will feature commissioned and non-commissioned content on topics including prospective biomarkers, mechanistic studies and comorbidity links.

More information on scope and submission can be found here

Why publish with ANC?

  • No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
  • Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
  • Rapid publication: publication within 2 months of submission
  • Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
  • Open access: enabling it to be read by a much larger set of readers, increasing its visibility
  • Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees

Articles

Sister journal

ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.

Read more here


Featured Review - Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids

Featured Article Picture

Real-time quaking-induced conversion assay (RT-QuIC) has established itself as a powerful diagnostic tool for sporadic Creutzfeldt-Jakob disease. Can it accurately discriminate between and diagnose other neurodegenerative diseases?

Read Niccolò Candelise et al.'s full review here.

Our Commitment to excellent author service

ANC is committed to rapid publication. We aim to publish all research articles within 2 months of submission, subject to authors responding to requests within the required timeframe. If the publication of your article exceeds 2 months from submission, you may be entitled to a full waiver or discount of the article-processing charge on your next submission. For further information, please read our FAQs or contact jjm.hoozemans@amsterdamumc.nl.

From the Editors-in-Chief

"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."

Jeroen Hoozemans, co-Editor-in-Chief, ANC

"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand.  ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead." 

Jason T. Huse, co-Editor-in-Chief, ANC

Annual Journal Metrics